Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Individual luteolysis pattern after GnRH-agonist trigger for final oocyte maturation.

Lawrenz B, Garrido N, Samir S, Ruiz F, Melado L, Fatemi HM.

PLoS One. 2017 May 1;12(5):e0176600. doi: 10.1371/journal.pone.0176600. eCollection 2017.

2.

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article.

Alyasin A, Mehdinejadiani S, Ghasemi M.

Int J Reprod Biomed (Yazd). 2016 Sep;14(9):557-566. Review.

3.

Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?

Palomba S, Santagni S, La Sala GB.

J Ovarian Res. 2015 Nov 19;8:77. doi: 10.1186/s13048-015-0205-8. Review.

4.
5.

Has ART Finally Got a Patient-Friendly Progesterone?

Allahbadia GN.

J Obstet Gynaecol India. 2015 Oct;65(5):289-92. doi: 10.1007/s13224-015-0731-8. No abstract available.

6.

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis.

Youssef MA, Abdelmoty HI, Ahmed MA, Elmohamady M.

J Adv Res. 2015 May;6(3):341-9. doi: 10.1016/j.jare.2015.01.005. Epub 2015 Jan 21. Review.

7.
8.
9.

Progesterone and the luteal phase: a requisite to reproduction.

Mesen TB, Young SL.

Obstet Gynecol Clin North Am. 2015 Mar;42(1):135-51. doi: 10.1016/j.ogc.2014.10.003. Epub 2015 Jan 5. Review.

10.

Timing luteal support in assisted reproductive technology: a systematic review.

Connell MT, Szatkowski JM, Terry N, DeCherney AH, Propst AM, Hill MJ.

Fertil Steril. 2015 Apr;103(4):939-946.e3. doi: 10.1016/j.fertnstert.2014.12.125. Epub 2015 Jan 29. Review.

11.

Assessment of the luteal phase in stimulated and substituted cycles.

Fatemi HM.

Facts Views Vis Obgyn. 2009;1(1):30-46. No abstract available.

12.

Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization.

Jayasena CN, Abbara A, Comninos AN, Nijher GM, Christopoulos G, Narayanaswamy S, Izzi-Engbeaya C, Sridharan M, Mason AJ, Warwick J, Ashby D, Ghatei MA, Bloom SR, Carby A, Trew GH, Dhillo WS.

J Clin Invest. 2014 Aug;124(8):3667-77. doi: 10.1172/JCI75730. Epub 2014 Jul 18.

13.

Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study.

Iliodromiti S, Lan VT, Tuong HM, Tuan PH, Humaidan P, Nelson SM.

J Ovarian Res. 2013 Dec 26;6(1):93. doi: 10.1186/1757-2215-6-93.

14.

Efficacy of luteal phase support with vaginal progesterone in intrauterine insemination: a systematic review and meta-analysis.

Miralpeix E, González-Comadran M, Solà I, Manau D, Carreras R, Checa MA.

J Assist Reprod Genet. 2014 Jan;31(1):89-100. doi: 10.1007/s10815-013-0127-6. Epub 2013 Nov 6. Review.

15.

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome.

Inamdar DB, Majumdar A.

J Hum Reprod Sci. 2012 Sep;5(3):279-84. doi: 10.4103/0974-1208.106341.

16.

The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis.

Liu XR, Mu HQ, Shi Q, Xiao XQ, Qi HB.

Reprod Biol Endocrinol. 2012 Dec 13;10:107. doi: 10.1186/1477-7827-10-107. Review.

17.

Preliminary clinical outcome of novel strategy for the maximization of cumulative pregnancy rates per retrieval in normal responders.

Joo JK, Choi JR, Son JB, Ko GR, Lee KS.

Clin Exp Reprod Med. 2012 Mar;39(1):33-9. doi: 10.5653/cerm.2012.39.1.33. Epub 2012 Mar 31.

18.

The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist.

Taylor JE, Miller BT, Gray KD, Scott RT Jr, Catherino WH, Segars JH.

Fertil Steril. 2010 Mar 15;93(5):1668-75. doi: 10.1016/j.fertnstert.2008.12.047. Epub 2009 Feb 6.

Supplemental Content

Support Center